Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: Clinical Features and Possible Immunopathogenesis
- 1 December 2010
- journal article
- case report
- Published by Elsevier BV in Seminars in Arthritis and Rheumatism
- Vol. 40 (3), 233-240
- https://doi.org/10.1016/j.semarthrit.2010.04.003
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- PsoriasisThe New England Journal of Medicine, 2009
- Myeloid dendritic cells correlate with clinical response whereas plasmacytoid dendritic cells impact autoantibody development in rheumatoid arthritis patients treated with infliximabArthritis Research & Therapy, 2009
- Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics RegisterAnnals Of The Rheumatic Diseases, 2008
- Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: report on five casesArchiv für dermatologische Forschung, 2008
- Tumor Necrosis Factor-α Inhibitor-Induced Psoriasis or Psoriasiform ExanthemataAmerican Journal of Clinical Dermatology, 2008
- Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007Annals Of The Rheumatic Diseases, 2007
- Development of new-onset psoriasis while on anti-TNF treatmentAnnals Of The Rheumatic Diseases, 2006
- Psoriasis after treatment of juvenile idiopathic arthritis with etanerceptAnnals Of The Rheumatic Diseases, 2006
- A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agentsAnnals Of The Rheumatic Diseases, 2006
- The Clustering of Other Chronic Inflammatory Diseases in Inflammatory Bowel Disease: A Population-Based StudyGastroenterology, 2005